Healwell Pharmaceuticals Private Limited
About Healwell Pharmaceuticals Private Limited
Data last updated:
Healwell Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36100DL2015PTC277562. Its GSTIN is 09AADCH5761M1Z3 (Uttar Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Atul Tulsian and Varsha Tulsian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 402 4th Floor Block No 1 Nav Nirman Apartment Sector – 2 Dwarka, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹13,094, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹45,638 (net margin -348.5%) and EBITDA of -₹34,606 (EBITDA margin -264.3%). Revenue has declined at a compounded annual rate (CAGR) of 70% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Healwell Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 402 4th Floor Block No 1 Nav Nirman Apartment Sector – 2 Dwarka, Delhi, India – 110075
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Healwell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Healwell Pharmaceuticals Private Limited
FY 2025 filings availableHealwell Pharmaceuticals Private Limited reported revenue of ₹13,094 (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 70%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹34,606 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹45,638 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -264.3% | ||||
| Net Profit Margin | -348.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Healwell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Healwell Pharmaceuticals Private Limited
Healwell Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Tulsian Also directs: Shree Ranisati Distributors Private Limited | Additional Director | 05 Jun 2019 | 7 Years 5 Months | Current |
| Varsha Tulsian | Additional Director | 05 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Healwell Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atrial Pharmaceuticals Private Limited | ₹13,815 (FY 2020) | -88.0% | Shimoga, Karnataka, India | |||
| Karnal Pharma Park Private Limited | ₹13,808 (FY 2024) | Karnal, Haryana, India | ||||
| L'amar Lifesciences & Biotech Private Limited | ₹13,711 (FY 2025) | 61.0% | Mumbai, Maharashtra, India | |||
| Zowie Health Care Private Limited (OPC) | ₹13,676 (FY 2022) | -84.0% | Greater Noida, Uttar Pradesh, India | |||
| Galaxystar Pharma Private Limited | ₹13,151 (FY 2022) | -93.0% | Mumbai, Maharashtra, India | |||
| Healwell Pharmaceuticals Private Limitedthis company | ₹13,094 (FY 2024) | -₹45,638 | -348.5% | 4.0% | Delhi, India | |
| Drish Lifesciences Limited | ₹13,039 (FY 2024) | 7.0% | Jalandhar, Punjab, India | |||
| Nurturaa Health Tech Private Limited | ₹13,000 (FY 2025) | Hyderabad, Telangana, India | ||||
| Bestowed Pharmaceuticals Private Limited | ₹12,960 (FY 2019) | 18.0% | Azamgarh, Uttar Pradesh, India | |||
| Biogenith Pharmaceuticals Private Limited | ₹12,886 (FY 2024) | Bikaner, Rajasthan, India | ||||
| Vytis Pharmaceuticals Private Limited | ₹12,720 (FY 2025) | -96.0% | Greater Noida, Uttar Pradesh, India |
To see the full peer comparison of Healwell Pharmaceuticals Private Limited, buy the company report.
Auditor
Healwell Pharmaceuticals Private Limited is audited by A V N & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A V N & ASSOCIATES | FY 2016 | 030043N |
Shareholding
The shareholding of Healwell Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Healwell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Healwell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Healwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Healwell Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCH5761M1Z3 | Uttar Pradesh | Active | 29 Nov 2019 |
To see the full GST registrations and return filing status of Healwell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Healwell Pharmaceuticals Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Amit Tulsian ceased to be Additional Director on 24 May 2024.
Frequently asked questions
Healwell Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 March 2015 (11+ years old) and is registered under CIN U36100DL2015PTC277562.
Healwell Pharmaceuticals has 2 current directors:
- Atul Tulsian - Additional Director
- Varsha Tulsian - Additional Director
The latest financial statements of Healwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Healwell Pharmaceuticals is 09AADCH5761M1Z3, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Healwell Pharmaceuticals is U36100DL2015PTC277562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Healwell Pharmaceuticals was incorporated on 05 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Healwell Pharmaceuticals by revenue are Atrial Pharmaceuticals Private Limited, Karnal Pharma Park Private Limited, L'amar Lifesciences & Biotech Private Limited, Zowie Health Care Private Limited (OPC), Galaxystar Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Amit Tulsian ceased to be Additional Director on 24 May 2024. Jagan Tulsian Prasad ceased to be Additional Director on 24 May 2024. Ankit Garg ceased to be Director on 11 Oct 2019. Healwell Pharmaceuticals has 8 board changes on record in total.
The registered office of Healwell Pharmaceuticals is at B – 402 4th Floor Block No 1 Nav Nirman Apartment Sector – 2 Dwarka, Delhi, India – 110075.
Healwell Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Healwell Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
